Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Ad5.F35-hGCC-PADRE |
Trade Name | |
Synonyms | Ad5-GUCY2C-PADRE |
Drug Descriptions |
Ad5.F35-hGCC-PADRE is a cancer vaccine comprising a recombinant type 5 adenovirus that encodes guanylyl cyclase C (GUCY2C) linked to a Pan DR Epitope (PADRE), which potentially enhances CD8-positive T-cell and antibody-mediated responses against GUCY2C-expressing tumor cells (Journal for ImmunoTherapy of Cancer 2015;3:P450). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C173640 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ad5.F35-hGCC-PADRE | Ad5.F35-hGCC-PADRE | 0 | 1 |